Skip to content

Azzamzeen NG: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Azzamzeen NG

BE 1010.431.281
NACE 86.220, Specialist medical practice
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€10,052
2024 · €40,247-€30,195
Equity
€55,300
2024 · €45,247+€10,052
Cash
€56,092
2024 · €37,584+€18,508
Balance sheet total
€63,736
2024 · €55,711+€8,025

Largest movements

2024 to 2025
Assets
  • Cash +€18,508

    up €18,508 (+49.2%), from €37,584 to €56,092

    mainly Receivables within one year (+€10,470) and Net result for the year (+€10,052)

  • Receivables within one year -€10,470

    down €10,470 (-59.7%), from €17,552 to €7,082

    of which Trade receivables: -€17,552

Equity and liabilities
  • Reserves +€10,052

    up €10,052 (+25.0%), from €40,247 to €50,300

  • Trade debts -€3,841

    down €3,841 (-77.5%), from €4,956 to €1,115

  • Other debts +€1,814

    up €1,814 (+218,529%), from €1 to €1,815

Income statement
  • Gross operating margin -€41,757

    down €41,757 (-74.8%), from €55,833 to €14,076

  • Taxes -€12,082

    down €12,082 (-77.9%), from €15,507 to €3,425

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €40,247
Gross operating margin -€41,757
Other operating charges -€437
Financial income +€0
Financial charges -€84
Taxes +€12,082
Result 2025 €10,052
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€18,508
Investment €0
Financing €0
Cash 2024 €37,584
Net result for the year +€10,052
Receivables within one year +€10,470
Deferred charges and accrued income +€14
Trade debts -€3,841
Other debts +€1,814
Cash 2025 €56,092
brings cash intakes cash out
Every line side by side 30 lines
Line Code 2024 2025 Change %
Total assets 20/58 €55,711 €63,736 +€8,025 +14.4%
Current assets 29/58 €55,711 €63,736 +€8,025 +14.4%
Amounts receivable within one year 40/41 €17,552 €7,082 -€10,470 -59.7%
Trade receivables 40 €17,552 - -€17,552
Other amounts receivable 41 - €7,082 +€7,082
Cash at bank and in hand 54/58 €37,584 €56,092 +€18,508 +49.2%
Deferred charges and accrued income 490/1 €576 €562 -€14 -2.4%
Total equity and liabilities 10/49 €55,711 €63,736 +€8,025 +14.4%
Equity 10/15 €45,247 €55,300 +€10,052 +22.2%
Contributions 10/11 €5,000 €5,000 = 0.0%
Reserves 13 €40,247 €50,300 +€10,052 +25.0%
Distributable reserves 133 €40,247 €50,300 +€10,052 +25.0%
Amounts payable 17/49 €10,464 €8,437 -€2,028 -19.4%
Amounts payable within one year 42/48 €10,464 €8,437 -€2,028 -19.4%
Trade debts 44 €4,956 €1,115 -€3,841 -77.5%
Suppliers 440/4 €4,956 €1,115 -€3,841 -77.5%
Taxes, remuneration and social security 45 €5,507 €5,507 = 0.0%
Taxes 450/3 €5,507 €5,507 = 0.0%
Other amounts payable 47/48 €1 €1,815 +€1,814 +218,529%
Other operating charges 640/8 €50 €487 +€437 +874%
Gross operating margin 9900 €55,833 €14,076 -€41,757 -74.8%
Operating profit (loss) 9901 €55,783 €13,589 -€42,194 -75.6%
Financial income 75/76B - €0 +€0
Recurring financial income 75 - €0 +€0
Financial charges 65/66B €28 €112 +€84 +299%
Recurring financial charges 65 €28 €112 +€84 +299%
Profit (loss) for the period before taxes 9903 €55,755 €13,478 -€42,277 -75.8%
Income taxes 67/77 €15,507 €3,425 -€12,082 -77.9%
Profit (loss) for the period 9904 €40,247 €10,052 -€30,195 -75.0%
Profit (loss) for the period to be appropriated 9905 €40,247 €10,052 -€30,195 -75.0%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.